Shree Ganesh Remedies Share Price | Shree Ganesh Remedies Stock Screener
SGRL
Pharmaceuticals
Share Price BSE
₹648.25
▼
-0.95 (-0.15%)
As of May 27, 2026, the Shree Ganesh Remedies share price (BSE: SGRL) is ₹648.25, down 0.15% from the previous close, with shares trading between ₹632.00 and ₹654.90, and a 52-week range of ₹400.40–₹653.75.
Check Shree Ganesh Remedies yearly highs lows for the annual price range and momentum.
Use the Shree Ganesh Remedies stock screener below to analyse P/E ratio, market cap, quarterly results, and more. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Shree Ganesh Remedies Market Cap
₹794.32 Cr.
SGRL P/E Ratio (TTM)
45.00
Shree Ganesh Remedies P/B Ratio
5.15
EPS (TTM)
₹13.83
Dividend Yield
-
Debt to Equity
0.28
SGRL 52 Week High
₹653.75
Shree Ganesh Remedies 52 Week Low
₹400.40
Operating Margin
34.00%
Profit Margin
17.65%
SGRL Revenue (TTM)
₹34.00
EBITDA
₹12.00
Net Income
₹6.00
Total Assets
₹208.00
Total Equity
₹163.00
Shree Ganesh Remedies Share Price Chart
Screen Shree Ganesh Remedies share price with an interactive chart. Analyse SGRL price trends and volatility across different timeframes.
Shree Ganesh Remedies Company Profile - Fundamental Screener
Screen Shree Ganesh Remedies company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for SGRL shares.
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
ISIN
INE414Y01015
Shree Ganesh Remedies Balance Sheet Screener
Screen SGRL balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2026 | 2025 | 2024 | 2020 | 2019 |
|---|---|---|---|---|---|
| Assets | |||||
| Total Assets | 208 | 192 | 171 | 55 | 41 |
| Current Assets | 86 | 78 | 70 | 34 | 26 |
| Fixed Assets | 118 | 95 | 81 | 20 | 15 |
| Liabilities | |||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 23 | 31 | 30 | 3 | 1 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | |||||
| Total Equity | 163 | 145 | 122 | 42 | 34 |
| Share Capital | 13 | 13 | 13 | 9 | 9 |
| Reserves & Surplus | 150 | 132 | 109 | 33 | 25 |
Shree Ganesh Remedies Income Statement Screener - Profit & Revenue Analysis
Screen Shree Ganesh Remedies income statement and profit fundamentals.
Analyze SGRL quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Shree Ganesh Remedies share price evaluation.
| Item | 2026-Mar | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec | 2021-Mar | 2021-Jun | 2021-Sept | 2021-Dec | 2020-Jun | 2020-Sept |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 34 | 27 | 25 | 31 | 22 | 39 | 25 | 33 | 28 | 16 | 14 | 17 | 22 | 10 | 12 |
| Expenses | 22 | 15 | 17 | 21 | 14 | 20 | 17 | 21 | 17 | 10 | 10 | 13 | 15 | 8 | 7 |
| EBITDA | 12 | 12 | 8 | 10 | 7 | 18 | 9 | 12 | 11 | 5 | 4 | 5 | 7 | 2 | 5 |
| Operating Profit % | 34.00% | 40.00% | 30.00% | 32.00% | 32.00% | 45.00% | 33.00% | 35.00% | 37.00% | 33.00% | 24.00% | 26.00% | 27.00% | 12.00% | 36.00% |
| Depreciation | 3 | 2 | 2 | 3 | 3 | 2 | 2 | 2 | 3 | 1 | 1 | 1 | 1 | 1 | 1 |
| Interest | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 9 | 9 | 5 | 7 | 4 | 16 | 6 | 9 | 8 | 4 | 3 | 4 | 6 | 1 | 4 |
| Tax | 3 | 2 | 1 | 2 | 1 | 4 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 1 | 1 |
| Net Profit | 6 | 7 | 4 | 5 | 3 | 13 | 5 | 6 | 5 | 3 | 2 | 3 | 4 | 1 | 3 |
| EPS | 4.88 | 5.13 | 2.68 | 3.86 | 2.41 | 10.01 | 3.62 | 4.97 | 4.22 | 3.03 | 4.68 | 3.02 | 3.50 | 0.85 | 6.18 |
Shree Ganesh Remedies Cash Flow Screener - Liquidity Fundamentals
Screen SGRL cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2025-March | 2024-March | 2020-March | 2019-March |
|---|---|---|---|---|
| Operating Activities | 31 | 31 | 5 | -5 |
| Investing Activities | -36 | -33 | -3 | 0 |
| Financing Activities | -1 | 10 | -1 | 0 |
| Net Cash Flow | -6 | 7 | 1 | -6 |
Shree Ganesh Remedies Shareholding Pattern Screener
See Shree Ganesh Remedies shareholding pattern with promoter, FII, and DII holdings.
Check Shree Ganesh Remedies promoter holding and ownership changes for SGRL on TickJournal.
| Item | 2026-Mar | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar | 2024-Jun | 2024-Sept |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 72.84% | 72.80% | 72.80% | 72.80% | 72.80% | 69.33% | 69.33% | 70.50% |
| FII Holding | 0.00% | 0.01% | 0.01% | 0.01% | 0.00% | 0.00% | 0.01% | 0.01% |
| DII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 24.97% | 24.89% | 24.87% | 24.92% | 24.95% | 28.14% | 28.51% | 27.23% |
| Other Holding | 2.19% | 2.31% | 2.32% | 2.27% | 2.25% | 2.53% | 2.15% | 2.26% |
| Shareholder Count | 8,058 | 8,978 | 9,166 | 8,752 | 8,442 | 7,049 | 7,186 | 8,508 |
Shree Ganesh Remedies Share Dividend Screener - Share Yield Analysis
Check Shree Ganesh Remedies dividend history with payout and yield data.
View Shree Ganesh Remedies dividend details including ex-dates and amounts for SGRL stock.
| Period | Dividend Per Share | Dividend Yield |
|---|---|---|
| 2026-March | ₹0.00 | 0.00% |
| 2025-March | ₹0.00 | 0.00% |
| 2024-March | ₹0.50 | 0.07% |
| 2023-March | ₹0.30 | 0.04% |
| 2022-March | ₹0.50 | 0.20% |
| 2021-March | ₹1.75 | 0.59% |
| 2020-March | ₹1.50 | 0.54% |
| 2019-March | ₹1.25 | 2.32% |
| 2018-March | ₹1.00 | 2.49% |
| 2017-March | ₹0.00 | 0.00% |
Shree Ganesh Remedies Stock Index Membership
See which indices include Shree Ganesh Remedies stock.
Check SGRL index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
Shree Ganesh Remedies Market Events Screener - Corporate Actions
Get Shree Ganesh Remedies corporate actions including splits, bonuses, and buybacks.
Check Shree Ganesh Remedies stock events that may affect SGRL share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| Annual General Meeting | NA | -5.12% | ||
| Dividend | ₹ 1.75 /share | 24.70% | ||
| Dividend | ₹ 0.50 /share | -19.88% | ||
| Annual General Meeting | NA | 4.64% | ||
| Dividend | ₹ 0.50 /share | 52.75% | ||
| 2026-05-14 | 2026-05-14 | Quarterly Result Announcement | NA | -5.03% |
| 2026-04-06 | 2026-04-06 | Extraordinary General Meeting | NA | -6.96% |
| 2026-01-23 | 2026-01-23 | Quarterly Result Announcement | NA | -3.18% |
| 2025-11-07 | 2025-11-07 | Quarterly Result Announcement | NA | -0.77% |
| 2025-08-01 | 2025-08-01 | Quarterly Result Announcement | NA | -3.35% |
| 2025-05-19 | 2025-05-19 | Quarterly Result Announcement | NA | 3.44% |
| 2025-02-05 | 2025-02-05 | Quarterly Result Announcement | NA | 33.42% |
| 2024-10-29 | 2024-10-29 | Quarterly Result Announcement | NA | -1.34% |
| 2023-02-03 | 2023-02-03 | Rights | 7:100 | -2.38% |
| 2021-11-01 | 2021-11-02 | Bonus | 1:5 | 13.55% |
Shree Ganesh Remedies Competitors Screener - Peer Comparison
Screen SGRL competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 441,670 | 40.42 | 58,220 | 6.38% | 11,565 | 54.06 |
| Divis Laboratories | 179,271 | 73.73 | 10,560 | 8.73% | 2,520 | 57.07 |
| Torrent Pharmaceuticals | 150,679 | 66.80 | 13,753 | 19.18% | 2,028 | 56.43 |
| Cipla | 114,503 | 29.26 | 27,712 | -2.46% | 3,783 | 64.74 |
| Dr Reddys Laboratories | 110,832 | 26.24 | 33,593 | -0.44% | 3,998 | 56.54 |
| Zydus Life Science | 108,578 | 20.40 | 26,720 | 13.65% | 5,242 | 74.62 |
| Lupin | 103,566 | 19.46 | 27,488 | 19.98% | 5,345 | 45.18 |
| Mankind Pharma | 100,047 | 52.84 | 14,278 | 12.03% | 1,750 | 55.67 |
| Aurobindo Pharma | 84,867 | 24.29 | 33,385 | 3.21% | 3,376 | 52.40 |
| Laurus Labs | 74,171 | 81.46 | 6,813 | 21.03% | 884 | 80.00 |
Shree Ganesh Remedies Company Announcements - News Screener
Screen SGRL latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-05-28 | Compliances-Reg.24(A)-Annual Secretarial Compliance | - |
| 2026-05-24 | Announcement under Regulation 30 (LODR)-Earnings Call Transcript | - |
| 2026-05-19 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | - |
| 2026-05-15 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-05-15 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | - |
| 2026-05-14 | Announcement under Regulation 30 (LODR)-Investor Presentation | - |
| 2026-05-14 | Board Meeting Outcome for Outcome Of Board Meeting | - |
| 2026-05-14 | Financial Results For Quarter And Financial Year Ended March 31 2026 | - |
| 2026-05-12 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | - |
| 2026-05-11 | Board Meeting Intimation for The Audited Standalone And Consolidated Financial Results Of The Company For The Quarter And Financial Year Ended On March 31 2026 | - |
| 2026-04-08 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |
| 2026-04-06 | Shareholder Meeting / Postal Ballot-Scrutinizer"s Report | - |
| 2026-04-06 | Shareholder Meeting / Postal Ballot-Outcome of EGM | - |
| 2026-03-21 | Closure of Trading Window | - |
| 2026-03-14 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-03-13 | Notice Of Extraordinary General Meeting | - |
| 2026-01-24 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-01-23 | Announcement under Regulation 30 (LODR)-Investor Presentation | - |
| 2026-01-23 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | - |
| 2026-01-23 | Financial Results For Quarter And Nine Months Ended December 31 2025 | - |